V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006742 | 280004116 | 1.67 | 86.1 | Curative (C) | 2017-03-04 | 2017-03-04 | CARBOPLATIN + FLUOROURACIL | N | N | 280030585 | PAZOPANIB |
| 280006743 | 280004117 | 1.61 | 67.8 | Adjuvant (A) | 2013-08-18 | 2013-09-11 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 280030758 | IVADO |
| 280006744 | 280004118 | 1.6 | 83 | Curative (C) | 2016-11-01 | 2016-11-03 | VIDE | 02 | N | 280030764 | IVA |
| 280006745 | 280004118 | 1.65 | 62 | null | 2018-11-05 | 2018-11-08 | GEDDIS TRIAL | N | null | 280030764 | TRABECTEDIN |
| 280006746 | 280004119 | 1.71 | 90.7 | null | 2018-03-17 | 2018-04-16 | Paclitaxel 80mg/m2 day 1 8 15 | N | Y | 280012866 | CARBO + FLUOROURACIL |
| 280006747 | 280004120 | 1.5 | 54.7 | Curative (C) | 2019-07-17 | 2019-07-24 | IVA | 2 | N | 280016093 | DE-ESCALATE TRIAL |
| 280006748 | 280004121 | 1.62 | 52.2 | Adjuvant (A) | 2018-02-20 | 2018-03-09 | IVADo | N | N | 280016987 | EURO-EWING |
| 280006749 | 280004122 | 1.8 | 92.65 | Adjuvant (A) | 2016-10-08 | 2016-10-08 | Pazopanib | N | N | 280017205 | BCG |
| 280006750 | 280004123 | 1.56 | 59.6 | Palliative (P) | 2018-01-31 | 2018-02-01 | Cisplatin + Fluorouracil + RT 5day | N | null | 280017406 | PACLITAXEL |
| 280006751 | 280004124 | 1.79 | null | Curative (C) | 2018-05-08 | 2018-05-08 | VDC | N | N | 280018386 | EURO-EWING |
| 280006752 | 280004125 | 1.79 | 115.7 | Palliative (P) | 2014-08-12 | 2014-08-20 | Mitomycin Intravesical | null | null | 280019392 | CAPECITABINE + TEMOZOLOMIDE |
| 280006753 | 280004126 | 1.68 | 50.6 | Neo-adjuvant (N) | 2013-07-19 | 2013-07-19 | ECX | 2 | Y | 280019654 | CISPLATIN + DOCETAXEL |
| 280006754 | 280008225 | 1.54 | 68 | Palliative (P) | 2017-07-20 | 2017-07-21 | Doxorubicin + Olaratumab | null | null | 280020288 | PACLITAXEL |
| 280006755 | 280004127 | 1.69 | 54.8 | Disease modification (D) | 2015-10-13 | 2017-10-11 | Capecitabine + Oxaliplatin 21day | N | N | 280020469 | VIDE |
| 280006756 | 280004127 | 1.83 | 90 | Curative (C) | 2018-04-07 | 2018-04-24 | GemCarbo Days 1+8 | N | Y | 280020469 | RMS 2005 TRIAL |
| 280006757 | 280004128 | 1.75 | 46.6 | Neo-adjuvant (N) | 2013-12-23 | 2014-01-03 | VAC | 2 | N | 280020838 | VIDE |
| 280006758 | 280004128 | 1.86 | 0 | Disease modification (D) | 2013-11-27 | 2013-12-23 | Liposomal Doxorubicin (Caelyx) | N | N | 280020838 | IMATINIB |
| 280006759 | 280004129 | 1.82 | 54.9 | Palliative (P) | 2014-02-13 | 2014-02-15 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | 280020851 | CYCLOPHOSPHAMIDE |
| 280006760 | 280004130 | null | null | null | null | 2013-10-19 | Etoposide + Ifosfamide (3 days) | null | null | 280021481 | VIDE |
| 280006761 | 280004130 | null | 52.1 | Curative (C) | 2017-07-26 | 2017-07-26 | LANREOTIDE | N | null | 280021481 | CAPECITABINE + MITOMYCIN |
| 280006762 | 280004131 | null | 62.6 | Not known (9) | 2019-06-11 | 2019-06-25 | Capecitabine + Oxaliplatin 21day | N | N | 280022015 | IMATINIB |
| 280006763 | 280004132 | 1.6 | 57 | Palliative (P) | 2015-02-16 | 2015-02-19 | Capecitabine + Oxaliplatin 21day | 02 | N | 280022482 | DOCETAXEL + GEMCITABINE |
| 280006764 | 280004133 | 1.81 | 77.6 | Palliative (P) | 2017-02-18 | 2017-02-22 | Carboplatin + Pemetrexed | N | N | 280022665 | CISPLATIN + DOXORUBICIN |
| 280006765 | 280004134 | 1.53 | 22.6 | Palliative (P) | 2017-12-02 | 2017-12-19 | CompARE Trial | 02 | N | 280022954 | DOXORUBICIN + OLARATUMAB |
| 280006766 | 280004134 | 1.73 | null | null | 2018-06-03 | 2018-06-07 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280022954 | ETOPOSIDE |
| 280006767 | 280004134 | 1.72 | 74.5 | Neo-adjuvant (N) | 2017-02-23 | 2017-03-08 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280022954 | CARBO + FLUOROURACIL |
| 280006768 | 280004134 | 1.7 | 88 | Curative (C) | 2015-03-10 | 2015-03-14 | CETUXIMAB + CISPLATIN + FU | N | N | 280022954 | IVA |
| 280006769 | 280004135 | null | null | Palliative (P) | 2014-12-07 | 2015-01-07 | DE-ESCALATE TRIAL | N | N | 280023556 | LIPOSOMAL DOXORUBICIN |
| 280006770 | 280008230 | null | 67.8 | Curative (C) | 2019-01-24 | 2019-01-25 | VIDE | N | null | 280023737 | COMPARE TRIAL |
| 280006771 | 280004136 | 1.53 | 64.2 | Curative (C) | 2016-12-28 | 2016-12-29 | Doxorubicin + Olaratumab | N | N | 280023786 | VAI |
| 280006772 | 280004137 | null | 76 | Palliative (P) | 2017-03-30 | 2017-04-02 | Paclitaxel 7 day | N | N | 280024558 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280006773 | 280008231 | 1.67 | 0 | Palliative (P) | 2018-12-27 | 2018-12-31 | Bendamustine+Rituximab (1st Course) | 02 | N | 280024571 | LIPOSOMAL DOXORUBICIN |
| 280006774 | 280004138 | 1.66 | 75.8 | Not known (9) | 2019-01-13 | 2019-01-28 | GemCarbo Days 1+8 | 02 | N | 280024966 | GEMCARBO |
| 280006775 | 280004138 | 1.76 | 46.5 | Neo-adjuvant (N) | 2016-10-28 | 2016-11-07 | Carboplatin + Pemetrexed | 2 | N | 280024966 | VIDE |
| 280006776 | 280004138 | 1.65 | 60 | Adjuvant (A) | 2017-10-04 | 2017-10-06 | Trabectedin | 02 | N | 280024966 | VIDE |
| 280006777 | 280004138 | 1.64 | 84 | Curative (C) | 2016-05-02 | 2016-05-31 | Cetuximab+Cisplatin+FU (> Cycle 2) | Y | Y | 280024966 | CISPLATIN + FLUOROURACIL + RT |
| 280006778 | 280004139 | 1.7 | null | Curative (C) | 2017-04-30 | 2017-05-01 | ETOPOSIDE | N | null | 280026143 | RMS 2005 TRIAL |
| 280006779 | 280004140 | 1.7 | 65 | Palliative (P) | 2019-05-23 | 2019-05-24 | Cyclophosphamide oral | N | N | 280026659 | DOXORUBICIN + OLARATUMAB |
| 280006780 | 280008233 | null | null | Palliative (P) | 2019-01-06 | 2019-01-07 | VIDE | Y | N | 280026665 | CISPLATIN + PEMETREXED |
| 280006781 | 280010169 | 1.54 | 28.25 | null | 2017-07-31 | 2017-08-08 | Carboplatin + Pemetrexed | N | null | 280027546 | ETOPOSIDE |
| 280006782 | 280010169 | null | null | Palliative (P) | null | 2015-10-09 | CETUXIMAB + IRINOTECAN + MDG | null | null | 280027546 | CAPECITABINE + CARBOPLATIN |
| 280006783 | 280010169 | 1.81 | 57.5 | Adjuvant (A) | 2018-02-13 | 2018-02-26 | Trabectedin | N | N | 280027546 | MITOMYCIN |
| 280006784 | 280010169 | null | 97.5 | null | 2018-12-20 | 2018-12-20 | IVA | null | null | 280027546 | RMS 2005 TRIAL |
| 280006785 | 280010169 | null | 69.4 | Curative (C) | 2017-03-29 | 2017-04-12 | Capecitabine + Cisplatin + RT | N | N | 280027546 | CVP R |
| 280006786 | 280010169 | 1.56 | 57 | Disease modification (D) | 2015-03-15 | 2015-03-17 | Oxaliplatin + Modified de Gramont | N | N | 280027546 | CARBO + FLUOROURACIL |
| 280006787 | 280010169 | -1 | 76 | Curative (C) | 2019-04-10 | 2019-04-15 | Carbo F | N | N | 280027546 | IVA |
| 280006788 | 280010169 | 1.57 | 60 | Curative (C) | 2018-04-24 | 2018-05-21 | Dactinomycin + Vincristine | 02 | Y | 280027546 | EURO-EWING |
| 280006789 | 280010169 | 1.71 | 70 | Disease modification (D) | 2018-04-07 | 2018-04-08 | GEMCITABINE | N | N | 280027546 | IFOSFAMIDE |
| 280006790 | 280012141 | 1.77 | 65.6 | Adjuvant (A) | 2015-09-17 | 2015-09-21 | GemCarbo Days 1+8 | 02 | N | 280026864 | PATHOS TRIAL |
| 280006791 | 280012141 | 1.65 | 122.9 | Palliative (P) | 2018-01-20 | 2018-02-13 | Trabectedin | null | null | 280026864 | TRABECTEDIN |